The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia
Clinical trial NCT02761460 · UNKNOWN
Trial details
- NCT number
- NCT02761460
- Sponsor
- wang shusen
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-04
- Primary completion
- 2018-04-01
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.